Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Proposed Australian Device Approval System Has Web-Based Application

This article was originally published in The Gray Sheet

Executive Summary

Legislation that would authorize a new regulatory system for medical devices will be reintroduced into the Australian Parliament as early as March

You may also be interested in...



Australian Medical Device Framework Takes Effect; Reuse Is On Horizon

Sponsors of the 20% of CE-marked Class I, Class IIa and Class IIb devices randomly selected to undergo an audit by Australia's Therapeutic Goods Administration will pay additional fees under the country's new medical device framework, which took effect Oct. 4

Australian Medical Device Framework Takes Effect; Reuse Is On Horizon

Sponsors of the 20% of CE-marked Class I, Class IIa and Class IIb devices randomly selected to undergo an audit by Australia's Therapeutic Goods Administration will pay additional fees under the country's new medical device framework, which took effect Oct. 4

Australia TGA To Hold May, June Seminars On New Device Regulation Laws

Australia's Therapeutic Goods Administration will draft guidance documents explaining legislative requirements under the recently enacted Therapeutic Goods Amendment (Medical Devices) Bill and the Therapeutic Goods (Charges) Amendment Bill

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015748

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel